1. Home
  2. KURA vs PRDO Comparison

KURA vs PRDO Comparison

Compare KURA & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • PRDO
  • Stock Information
  • Founded
  • KURA 2014
  • PRDO 1994
  • Country
  • KURA United States
  • PRDO United States
  • Employees
  • KURA N/A
  • PRDO N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • PRDO Other Consumer Services
  • Sector
  • KURA Health Care
  • PRDO Real Estate
  • Exchange
  • KURA Nasdaq
  • PRDO Nasdaq
  • Market Cap
  • KURA 1.5B
  • PRDO 1.4B
  • IPO Year
  • KURA N/A
  • PRDO N/A
  • Fundamental
  • Price
  • KURA $19.29
  • PRDO $21.33
  • Analyst Decision
  • KURA Strong Buy
  • PRDO Buy
  • Analyst Count
  • KURA 6
  • PRDO 1
  • Target Price
  • KURA $30.60
  • PRDO $30.00
  • AVG Volume (30 Days)
  • KURA 434.9K
  • PRDO 330.5K
  • Earning Date
  • KURA 10-31-2024
  • PRDO 10-31-2024
  • Dividend Yield
  • KURA N/A
  • PRDO 2.44%
  • EPS Growth
  • KURA N/A
  • PRDO 9.56
  • EPS
  • KURA N/A
  • PRDO 2.04
  • Revenue
  • KURA N/A
  • PRDO $662,846,000.00
  • Revenue This Year
  • KURA N/A
  • PRDO N/A
  • Revenue Next Year
  • KURA N/A
  • PRDO $4.00
  • P/E Ratio
  • KURA N/A
  • PRDO $10.48
  • Revenue Growth
  • KURA N/A
  • PRDO N/A
  • 52 Week Low
  • KURA $7.41
  • PRDO $16.01
  • 52 Week High
  • KURA $24.17
  • PRDO $26.40
  • Technical
  • Relative Strength Index (RSI)
  • KURA 42.25
  • PRDO 33.44
  • Support Level
  • KURA $19.93
  • PRDO $21.61
  • Resistance Level
  • KURA $21.57
  • PRDO $22.82
  • Average True Range (ATR)
  • KURA 0.74
  • PRDO 0.56
  • MACD
  • KURA -0.01
  • PRDO -0.14
  • Stochastic Oscillator
  • KURA 6.56
  • PRDO 4.02

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segment include the American InterContinental University, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services with majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.

Share on Social Networks: